Metformin × glycemic control

TrialDiabetologia2013

Efficacy and safety over 26 weeks of an oral treatment strategy including sitagliptin compared with an injectable treatment strategy with liraglutide in patients with type 2 diabetes mellitus inadequately controlled on metformin: a randomised clinical trial.

B Charbonnel et al.PubMed ↗Publisher ↗

What the trial testedas reported · 653 people · 2013

Not counted

Probably lowered glycemic control

−1.30percentage points−1.40 to −1.20

As reported

difference −1.3 %, 95% CI −1.40 to −1.20

One number in the abstract

the abstract, start to end

LS mean change in HbA1c at week 26 was -1.3% (95% CI -1.4, -1.2) in the

← favours treatmentfavours comparator →
could be chance
Glycemic control
−1.3−1.40 to −1.20
MetforminGlycemic control
1 / 3

36 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 23604551